News
February 12, 2018
Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials
Toronto, Canada – Nanovista Inc. (“Nanovista”) develops multimodal visualization agents designed to improve the performance of image-guided high-precision cancer therapy. The seed round financing was led by GreenSky Capital Inc. and its affiliated venture funds, the GreenSky Accelerator Funds I and GreenSky Accelerator Funds II, who made a $750,000 lead investment as part of a $2.3M seed round investment.
December 18, 2017
Nanovista is named one of “Ten Start-ups Changing Healthcare” by Scientific American
“The Toronto-based firm’s first product works with multiple imaging technologies, remains effective for up to two weeks and was successfully tested on 10 different human and animal tumor types.”
November 4, 2016
Nanovista featured in MaRS Special Report: Urban Innovation
ON THE COVER:
Shot on the MaRS Centre rooftop: (left to right) Curtis VanWalleghem, CEO of Hydrostor; Lindsey Goodchild, Co-founder and CEO, Nudge; Marie Chevrier, Founder and CEO, Sampler; Jinzi Zheng, co-founder, Nanovista; Mike Andrade, CEO, Morgan Solar; Tom Rodinger, co-founder and CTO, Nanoleaf; Kelly Shaw, President and CEO, OOKA Island.
“A near-perfect blend of scientific know-how and business acumen leads to cutting-edge medical breakthroughs and technological advances.”
From “MaRS Special Report: Urban Innovation”, Page 11
Click here to add your own text